| Nov 11 |
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
|
| Nov 6 |
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previo...
|
| Oct 30 |
Pleasing Signs As A Number Of Insiders Buy Scilex Holding Stock
|
| Oct 30 |
Scilex Pharmaceuticals announces end of phase II meeting with FDA for SP-103
|
| Oct 16 |
Scilex gains on spinoff plans for pharma subsidiary
|
| Oct 16 |
Scilex Holding Company Announces that its Board of Directors has Authorized Management to Explore Ways to Maximize the Value of its Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., including by way of conducting a spinoff or public listing of secu...
|
| Oct 16 |
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semn...
|
| Oct 7 |
Scilex Holding Starts $50 Million Registered Direct Offering of Convertible Notes
|
| Oct 7 |
Scilex Holding Company Announces Signing of a $50 Million Registered Convertible Financing to Refinance and Restructure Existing Debt & Further Strengthens Financial Profile
|
| Sep 26 |
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to January 31, 2025
|
